MYLAN SM 25 MYLAN SM 25 Pill - brown & yellow capsule/oblong, 18mm
Pill with imprint MYLAN SM 25 MYLAN SM 25 is Brown & Yellow, Capsule/Oblong and has been identified as Sunitinib Malate 25 mg. It is supplied by Mylan Pharmaceuticals Inc.
Sunitinib is used in the treatment of Renal Cell Carcinoma; Pancreatic Cancer; Gastrointestinal Stromal Tumor and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Sunitinib 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for MYLAN SM 25 MYLAN SM 25
Sunitinib Malate
- Imprint
- MYLAN SM 25 MYLAN SM 25
- Strength
- 25 mg
- Color
- Brown & Yellow
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors, VEGF/VEGFR inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-6679
- Inactive Ingredients
-
silicon dioxide,
croscarmellose sodium,
gelatin,
magnesium stearate,
mannitol,
sodium lauryl sulfate,
titanium dioxide,
ferric oxide red,
ferric oxide yellow,
ammonia,
ferrosoferric oxide,
propylene glycol,
shellac
Note: Inactive ingredients may vary.
Related images for "MYLAN SM 25 MYLAN SM 25"
More about sunitinib
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (35)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
